Podcast Episodes

Back to Search
Both Tongwei Jintang bases have obtained national level green factory certification
Both Tongwei Jintang bases have obtained national level green factory certification

Smf5Yv7iSAZW7lGwgunC

5 months ago

Short Long
View Episode
Anchoring the new AI track, Transsion Holdings embarks on a new journey of global intellig
Anchoring the new AI track, Transsion Holdings embarks on a new journey of global intellig

Smf5Yv7iSAZW7lGwgunC

5 months ago

Short Long
View Episode
The registration phase III clinical trial of the new BCLtwo inhibitor Mesutoclax combined
The registration phase III clinical trial of the new BCLtwo inhibitor Mesutoclax combined

Smf5Yv7iSAZW7lGwgunC

5 months ago

Short Long
View Episode
Tongwei Green Material (Inner Mongolia) has obtained QESEn certification from China Classi
Tongwei Green Material (Inner Mongolia) has obtained QESEn certification from China Classi

Smf5Yv7iSAZW7lGwgunC

5 months ago

Short Long
View Episode
Transsion Holdings: From Hardware Going Global to Ecological Going Global, AI Strategy Res
Transsion Holdings: From Hardware Going Global to Ecological Going Global, AI Strategy Res

Smf5Yv7iSAZW7lGwgunC

5 months ago

Short Long
View Episode
Green Tea Group releases positive profit forecast for two thousand twenty-five, with net p
Green Tea Group releases positive profit forecast for two thousand twenty-five, with net p

Smf5Yv7iSAZW7lGwgunC

5 months ago

Short Long
View Episode
Dalipu reports profits: Expected to turn losses into profits for the whole year of two tho
Dalipu reports profits: Expected to turn losses into profits for the whole year of two tho

Smf5Yv7iSAZW7lGwgunC

5 months ago

Short Long
View Episode
Tongwei Green Material (Inner Mongolia) has obtained QESEn certification from China Classi
Tongwei Green Material (Inner Mongolia) has obtained QESEn certification from China Classi

Smf5Yv7iSAZW7lGwgunC

5 months, 2 weeks ago

Short Long
View Episode
The first patient enrolled in the Phase II/III clinical trial of the new TYKtwo inhibitor
The first patient enrolled in the Phase II/III clinical trial of the new TYKtwo inhibitor

Smf5Yv7iSAZW7lGwgunC

5 months, 2 weeks ago

Short Long
View Episode
Wanneng Electric Power Shareholders' Meeting Release Development Signal, New Energy Layout
Wanneng Electric Power Shareholders' Meeting Release Development Signal, New Energy Layout

Smf5Yv7iSAZW7lGwgunC

5 months, 2 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us